Patient Leaflet Updated 22-Sep-2026 | Flamingo Pharma (UK) Ltd
Pregabalin Flamingo 25 mg, 50 mg, 75 mg, 100 mg, 225 mg and 300 mg hard capsules
Pregabalin Flamingo 25 mg, 50 mg, 75 mg, 100 mg, 225 mg and 300 mg hard capsules
pregabalin
This medicine contains pregabalin, which can cause dependence, tolerance and addiction. You can get withdrawal symptoms if you stop taking it or reduce the dose suddenly. If this medicine is being used for the treatment of epilepsy you must continue to take this medicine as instructed by your doctor.
1. What pregabalin capsules are and what they are used for
2. What you need to know before you take pregabalin capsules
3. How to take pregabalin capsules
4. Possible side effects
5. How to store pregabalin capsules
6. Contents of the pack and other information
Pregabalin is used to treat long lasting pain caused by damage to the nerves. A variety of diseases can cause peripheral neuropathic pain, such as diabetes or shingles.
Pain sensations may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbance, fatigue (tiredness), and can have an impact on physical and social functioning and overall quality of life.
Epilepsy: Pregabalin is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation) in adults. Your doctor will prescribe Pregabalin for you to help treat your epilepsy when your current treatment is not controlling your condition. You should take Pregabalin in addition to your current treatment. Pregabalin is not intended to be used alone, but should always be used in combination with other anti-epileptic treatment.
Generalised Anxiety Disorder: Pregabalin is used to treat Generalised Anxiety Disorder (GAD). The symptoms of GAD are prolonged excessive anxiety and worry that are difficult to control. GAD can also cause restlessness or feeling keyed up or on edge, being easily fatigued (tired), having difficulty concentrating or mind going blank, feeling irritable, having muscle tension or sleep disturbance. This is different to the stresses and strains of everyday life.
Gabapentinoids can cause dependence, tolerance and addiction, and you may get withdrawal symptoms if you stop taking it or reduce the dose suddenly. Your prescriber should have explained how long you will be taking it for and, when it is appropriate to stop, how to do this safely. When your treatment is stopped, it is usually done gradually over a period which is specific to you and may occur over a period of weeks to months. If this medicine is being used for the treatment of epilepsy you must continue to take it as prescribed by your doctor.
If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Talk to your doctor or pharmacist before taking Pregabalin.
Dependence
Taking this medicine regularly, particularly for a long time, can lead to physical dependence and addiction. Your prescriber should have explained how long you will be taking it for and, when it is appropriate to stop, how to do this safely. When your treatment is stopped, it is usually done gradually over a period which is specific to you and may occur over a period of weeks to months. Physical dependence and addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include trouble sleeping, headache, nausea, feeling anxious, diarrhoea, flu-like symptoms, convulsions, nervousness, depression, thoughts of harming or killing yourself, pain, sweating, and dizziness.
Your prescriber will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop taking the medicine suddenly as you will be more likely to experience withdrawal symptoms. Your prescriber will ensure that your plan for stopping treatment is tailored to you and can be adapted according to your needs and experience of any withdrawal symptoms.
Gabapentinoids should only be used by those they are prescribed for. Do not give your medicine to anyone else. Taking higher doses or more frequent doses of gabapentinoids may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.
Some people may become dependent on Pregabalin (a need to keep taking the medicine).
They may have withdrawal effects when they stop using Pregabalin (see section 3, “How to take Pregabalin” and “If you stop taking Pregabalin”).
If you have concerns that you may become dependent on Pregabalin, it is important that you consult your doctor.
If you notice any of the following signs whilst taking Pregabalin, it could be a sign that you have become dependent:
If you notice any of these, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to do this safely.
The safety and efficacy in children and adolescents (under 18 years of age) has not been established and therefore, pregabalin should not be used in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines
Pregabalin and certain other medicines may influence each other (interaction). When taken with certain other medicines which have sedative effects (including opioids), Pregabalin may potentiate these effects, and could lead to respiratory failure, coma and death. The degree of dizziness, sleepiness and decreased concentration may be increased if Pregabalin is taken together with medicines containing:
Oxycodone – (used as a pain-killer)
Lorazepam – (used for treating anxiety)
Alcohol
Pregabalin may be taken with oral contraceptives.
Pregabalin capsules may be taken with or without food.
It is advised not to drink alcohol while taking Pregabalin.
Pregabalin should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor. Pregabalin use during the first 3 months of pregnancy may cause birth defects in the unborn child that require medical treatment.
In a study reviewing data from women in Nordic countries who took pregabalin in the first 3 months of pregnancy, 6 babies in every 100 had such birth defects. This compares to 4 babies in every 100 born to women not treated with pregabalin in the study. Abnormalities of the face (orofacial clefts), the eyes, the nervous system (including the brain), kidneys and genitals have been reported.
Effective contraception must be used by women of childbearing potential. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregabalin may produce dizziness, sleepiness and decreased concentration. You should not drive, operate complex machinery or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Do not take more medicine than prescribed.
Your doctor will determine what dose is appropriate for you. Your prescriber should have discussed with you how long the course of capsules will last. They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and stop taking the medicine. Your prescriber will ensure that your plan for stopping treatment is tailored to you and can be adapted according to your needs and experience of any withdrawal symptoms.
Pregabalin is for oral use only.
If you have the impression that the effect of Pregabalin is too strong or too weak, talk to your doctor or pharmacist.
If you are an elderly patient (over 65 years of age), you should take Pregabalin normally except if you have problems with your kidneys.
Your doctor may prescribe a different dosing schedule and/or dose if you have problems with your kidneys.
Swallow the capsule whole with water.
Continue taking Pregabalin until your doctor tells you to stop.
Call your doctor or go to the nearest hospital emergency unit immediately. Take your box of Pregabalin capsules with you. You may feel sleepy, confused, agitated, or restless as a result of taking more Pregabalin than you should. Fits and unconsciousness (coma) have also been reported.
It is important to take your Pregabalin capsules regularly at the same time each day. If you forget to take a dose, take it as soon as you remember unless it is time for your next dose. In that case, just carry on with the next dose as normal. Do not take a double dose to make up for a forgotten dose.
Do not suddenly stop taking Pregabalin. If you want to stop taking Pregabalin, discuss this with your doctor first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. This may occur over a period of weeks to months. Your prescriber will ensure that your plan for stopping treatment is tailored to you and can be adapted according to your needs and experience of any withdrawal symptoms.
Withdrawal symptoms such as trouble sleeping, headache, nausea, feeling anxious, diarrhoea, flu-like symptoms, convulsions, nervousness, depression, thoughts of harming or killing yourself, pain, sweating, and dizziness. These effects may occur more commonly or severely if you have been taking Pregabalin for a longer period of time. If you experience withdrawal effects, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common: may affect more than 1 in 10 people
Dizziness, drowsiness, headache.
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from the available data
Drug Withdrawal
When you stop taking Pregabalin capsules, you may experience drug withdrawal symptoms, which include trouble sleeping, headache, nausea, feeling anxious, diarrhoea, flu-like symptoms, convulsions, nervousness, depression, thoughts of harming or killing yourself, pain, sweating, and dizziness.
If you experience swollen face or tongue or if your skin turns red and starts to blister or peel, you should seek immediate medical advice.
If you notice any of the following signs whilst taking Pregabalin capsules, it could be a sign that you have become addicted.
If you notice any of these signs, it is important you talk to your prescriber.
Certain side effects may be more common, such as sleepiness, because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, that have similar side effects to Pregabalin and the severity of these effects may be increased when taken together.
The following adverse reaction has been reported in the post marketing experience: Trouble breathing, shallow breaths.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister.
The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The other ingredients are pregelatinised starch, purified talc
Capsules shell for pregabalin 25 mg and 50 mg hard capsules are made of titanium dioxide (E171), gelatine and purified water.
Capsules shell for pregabalin 75mg hard capsules are made of titanium dioxide (E171) , iron oxide red (E172), gelatine and purified water.
Capsules shell for pregabalin 100mg, 225mg and 300mg hard capsules are made of titanium dioxide (E171), iron oxide red & iron oxide yellow (E172), gelatine and purified water.
The ink used to print on the capsules contains shellac (E904), black iron oxide (E171) and propylene glycol (E1520).
25mg- size "4" hard gelatin capsule, white opaque cap imprinted with “PRG” & white opaque body imprinted with “25” containing white to off-white powder or powder plug. Capsule Length: 14.40 mm
50mg- size "3" hard gelatin capsule, white opaque cap imprinted with “PRG” & white opaque body imprinted with “50”, containing white to off-white powder or powder plug. Capsule Length:15.80 mm
75mg- size "4" hard gelatin capsule, brownish red opaque cap imprinted with “PRG” & white opaque body imprinted with “75”, containing white to off-white powder or powder plug. Capsule Length: 14.40 mm
100mg- size "3" hard gelatin capsule, orange opaque cap imprinted with “PRG” & orange opaque body imprinted with “100”, containing white to off-white powder or powder plug. Capsule Length: 15.80 mm
225mg- size "1" hard gelatin capsule, white opaque cap imprinted with “PRG” & orange opaque body imprinted with “225”, containing white to off-white powder or powder plug. Capsule Length: 19.30 mm
300mg- size "0" hard gelatin capsule, opaque cap imprinted with “PRG” & white opaque body imprinted with “300”, containing white to off-white powder or powder plug. Capsule Length: 21.40 mm
These capsules are available in clear film aluminium - PVC and aluminium - PVC/PVDC blister packs of 14, 56, 84, 100, and 112 capsules.
Not all pack sizes may be marketed.
25 mg- PL 43461/0198, 50 mg- PL 43461/0199
75 mg- PL 43461/0200, 100 mg- PL 43461/0201
225 mg- PL 43461/0202, 300 mg- PL 43461/0203
This leaflet was last revised in 08/2026.
For information in large print, Braille or on CD, telephone please contact the MAH on above address.
POM
MPLLPREXXXXCPCOM
FPLXXX505V01_A
The BLOC, 38 Springfield Way, Kingston Upon Hull, HU10 6RJ, UK
+44 8000668348
+44 (0) 7784240228
http://www.flamingopharma.co.uk